{"id":18774,"date":"2025-06-02T14:57:38","date_gmt":"2025-06-02T12:57:38","guid":{"rendered":"https:\/\/adragos-pharma.com\/3-tendances-cdmo-faconnant-lindustrie-pharmaceutique-en-2025-perspectives-de-notre-cco-henny-zijlstra\/"},"modified":"2025-07-09T14:24:36","modified_gmt":"2025-07-09T12:24:36","slug":"3-tendances-cdmo-qui-faconneront-la-pharma-en-2025","status":"publish","type":"post","link":"https:\/\/adragos-pharma.com\/fr\/3-tendances-cdmo-qui-faconneront-la-pharma-en-2025\/","title":{"rendered":"3 tendances CDMO qui fa\u00e7onneront la pharma en 2025"},"content":{"rendered":"\n<p>Dans une r\u00e9cente table ronde de <strong>Contract Pharma<\/strong>, les leaders de l&rsquo;industrie ont discut\u00e9 des principales tendances impactant les CDMO en 2025 et au-del\u00e0. Notre propre CCO, <strong>Henny Zijlstra<\/strong>, a apport\u00e9 son expertise \u00e0 la conversation, mettant en lumi\u00e8re trois domaines critiques que les CDMO doivent aborder cette ann\u00e9e. <\/p>\n\n\n\n<p>Henny approfondit :<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Consolidation des r\u00e9seaux CDMO :<\/strong> Exploration de la mani\u00e8re dont les fusions et acquisitions remod\u00e8lent le paysage.<\/li>\n\n\n\n<li><strong>Num\u00e9risation centr\u00e9e sur le client :<\/strong> Examen de l&rsquo;importance des outils num\u00e9riques dans l&rsquo;am\u00e9lioration des relations clients et la gestion de projet.<\/li>\n\n\n\n<li><strong>Poursuite de la relocalisation des projets :<\/strong> Analyse des facteurs motivant la tendance \u00e0 la relocalisation et ses implications pour les CDMO.<\/li>\n<\/ul>\n\n\n\n<p>Vous souhaitez comprendre comment ces tendances impacteront vos strat\u00e9gies de d\u00e9veloppement et de fabrication pharmaceutiques ? Lisez les perspectives compl\u00e8tes de Henny et l&rsquo;int\u00e9gralit\u00e9 de la discussion de la table ronde sur Contract Pharma : <a href=\"https:\/\/www.contractpharma.com\/cdmos-key-leader-insights\/%20\" target=\"_blank\" rel=\"noopener\">https:\/\/www.contractpharma.com\/cdmos-key-leader-insights\/ <\/a>  <\/p>\n","protected":false},"excerpt":{"rendered":"<p>Dans une r\u00e9cente table ronde de Contract Pharma, les leaders de l&rsquo;industrie ont discut\u00e9 des principales tendances impactant les CDMO en 2025 et au-del\u00e0. Notre propre CCO, Henny Zijlstra, a apport\u00e9 son expertise \u00e0 la conversation, mettant en lumi\u00e8re trois [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":17888,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"content-type":"","inline_featured_image":false,"footnotes":""},"categories":[185],"tags":[303],"topics":[78],"locations":[],"experts":[60],"class_list":["post-18774","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-blog","tag-cdmo-fr","topics-cdmo","experts-henny-zijlstra"],"_links":{"self":[{"href":"https:\/\/adragos-pharma.com\/fr\/wp-json\/wp\/v2\/posts\/18774","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/adragos-pharma.com\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/adragos-pharma.com\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/adragos-pharma.com\/fr\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/adragos-pharma.com\/fr\/wp-json\/wp\/v2\/comments?post=18774"}],"version-history":[{"count":2,"href":"https:\/\/adragos-pharma.com\/fr\/wp-json\/wp\/v2\/posts\/18774\/revisions"}],"predecessor-version":[{"id":20020,"href":"https:\/\/adragos-pharma.com\/fr\/wp-json\/wp\/v2\/posts\/18774\/revisions\/20020"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/adragos-pharma.com\/fr\/wp-json\/wp\/v2\/media\/17888"}],"wp:attachment":[{"href":"https:\/\/adragos-pharma.com\/fr\/wp-json\/wp\/v2\/media?parent=18774"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/adragos-pharma.com\/fr\/wp-json\/wp\/v2\/categories?post=18774"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/adragos-pharma.com\/fr\/wp-json\/wp\/v2\/tags?post=18774"},{"taxonomy":"topics","embeddable":true,"href":"https:\/\/adragos-pharma.com\/fr\/wp-json\/wp\/v2\/topics?post=18774"},{"taxonomy":"locations","embeddable":true,"href":"https:\/\/adragos-pharma.com\/fr\/wp-json\/wp\/v2\/locations?post=18774"},{"taxonomy":"experts","embeddable":true,"href":"https:\/\/adragos-pharma.com\/fr\/wp-json\/wp\/v2\/experts?post=18774"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}